Current Topics in Medicinal Chemistry

Editor-in-Chief:

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
USA

Back

Become EABM
Become Reviewer

Why Do We Need New Drug Classes for HIV Treatment and Prevention?

Volume:16   Issue: 12
Pp: 1343-1349
Abdul A. Waheed and Gilda Tachedjian
DOI: 10.2174/1568026616999151013124606



Editorial (Thematic Issue: Medicinal Chemistry of Hepatitis C Virus: Current and Future Perspective) free to download

Volume:16   Issue: 12
Pp: 1350-1350
HaiWei Xu
DOI: 10.2174/156802661612160303150629

Current Drug Discovery for Anti-hepatitis C Virus Targeting NS4B

Volume:16   Issue: 12
Pp: 1362-1371
Zhenya Wang, Xinli Chen, Chunli Wu, Haiwei Xu and Hongmin Liu
DOI: 10.2174/1568026616666151120112642

A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors

Volume:16   Issue: 12
Pp: 1372-1382
Yan A. Ivanenkov, Mark S. Veselov, Artem G. Shakhbazyan, Vladimir A. Aladinskiy, Anastasia V. Aladinskaya, Sofya M. Yartseva, Alexander G. Majouga, Anton S. Vantskul, Sergey V. Leonov, Alexandre V. Ivachtchenko and Victor E. Koteliansky
DOI: 10.2174/1568026616666151120113040

In Silico Approaches to the Design of NS5A Inhibitors

Volume:16   Issue: 12
Pp: 1383-1391
Yan A. Ivanenkov, Mark S. Veselov, Vladimir A. Aladinskiy, Artem G. Shakhbazyan, Sofya M. Yartseva, Alexander G. Majouga, Anastasia V. Aladinskaya, Anton S. Vantskul, Sergey V. Leonov, Alexandre V. Ivachtchenko and Victor E. Koteliansky
DOI: 10.2174/1568026616666151120113705

New Non-Nucleocide NS5B Protein Inhibitors for the Treatment of Chronic Hepatitis C Infection

Volume:16   Issue: 12
Pp: 1392-1401
Li-hong Shan, Ying Liu, Yong-hong Li, Hong-min Liu and Yu Ke
DOI: 10.2174/1568026616666151120113933

HCV Inhibitors: Role of Compounds from Botanical Sources

Volume:16   Issue: 12
Pp: 1402-1409
Vaishali M. Patil, Neeraj Masand and Satya Prakash Gupta
DOI: 10.2174/1568026616666151120112802